Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-045776
Filing Date
2024-11-06
Accepted
2024-11-06 16:42:41
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 contexttherapeuticss-3nov2.htm S-3 320900
2 EX-FILING FEES exhibit107-sx3nov2024.htm EX-FILING FEES 22626
3 EX-4.3 exhibit43-sx3nov2024.htm EX-4.3 434299
4 EX-5.1 exhibit51-sx3nov2024.htm EX-5.1 42582
5 EX-23.2 exhibit232-sx3nov2024.htm EX-23.2 3095
6 contexttherapeuticsimage.jpg GRAPHIC 32139
7 faegre.jpg GRAPHIC 39280
  Complete submission text file 0001628280-24-045776.txt   923158
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283037 | Film No.: 241431739
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)